NM_020223.4(FAM20C):c.953_956+30dup AND not provided

This record was updated by the submitter. Please see the current version.

Germline classification:: Benign (1 submission)
Last evaluated:: Jun 19, 2017
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000948320.1

Allele description

NM_020223.4(FAM20C):c.953_956+30dup

Gene:

FAM20C:FAM20C golgi associated secretory pathway kinase [Gene - OMIM - HGNC]

Variant type:

Duplication

Cytogenetic location:

7p22.3

Genomic location:

Preferred name:

NM_020223.4(FAM20C):c.953_956+30dup

HGVS:

NC_000007.14:g.246504_246537dup
NG_033970.1:g.56140_56173dup
NM_020223.4:c.953_956+30dupMANE SELECT
NC_000007.13:g.286468_286469insGACAGGTGAGCCCTTCCTTCCTCCCTCCATCCGC
NC_000007.13:g.286470_286503dup
NM_020223.3:c.953_956+30dupACAGGTGAGCCCTTCCTTCCTCCCTCCATCCGCG

Links:

dbSNP: rs771282640

NCBI 1000 Genomes Browser:

rs771282640

Molecular consequence:

NM_020223.4:c.953_956+30dup - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Identifiers:: MedGen: CN517202

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001094523	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Benign (Jun 19, 2017)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001094523

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Benign
(Jun 19, 2017)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV001094523.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jul 7, 2021

ClinVar

Relating variation to medicine